ARTELO BIOSCIENCES, INC. Proceeds from Related Party Debt
ARTELO BIOSCIENCES, INC. (ARTL) reported Proceeds from Related Party Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2023-03-31
- ARTELO BIOSCIENCES, INC. proceeds from related party debt for the quarter ending 2021-11-30 was $0.00, a 100.00% decline year-over-year.
- ARTELO BIOSCIENCES, INC. proceeds from related party debt for the quarter ending 2021-08-31 was -$392.00, a 144.34% decline year-over-year.
- ARTELO BIOSCIENCES, INC. proceeds from related party debt for the quarter ending 2021-05-31 was $0.00, a 100.00% decline year-over-year.
- ARTELO BIOSCIENCES, INC. proceeds from related party debt for the quarter ending 2021-02-28 was $392.00, a 81.21% decline year-over-year.
- ARTELO BIOSCIENCES, INC. proceeds from related party debt for fiscal 2022 was $0.00.
- ARTELO BIOSCIENCES, INC. proceeds from related party debt for fiscal 2021 was $1.00K, a 87.50% decline from fiscal 2020.
- ARTELO BIOSCIENCES, INC. proceeds from related party debt for fiscal 2020 was $8.00K, a 56.23% decline from fiscal 2019.
- ARTELO BIOSCIENCES, INC. proceeds from related party debt for fiscal 2019 was $18.28K, a 8.13% decline from fiscal 2018.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 3 month as first filed | Proceeds from Related Party Debt 4 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month | Proceeds from Related Party Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 | ||||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | ||||||
| 2021-11-30 | $0.00 10-Q · filed 2022-01-12 | -$392.00 derived: sum of 2 quarters · filed 2023-03-31 | -$392.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2021-08-31 | -$392.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$392.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $1.00K 10-K · filed 2023-03-31 | |||
| 2021-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | $392.00 derived: sum of 2 quarters · filed 2021-07-12 | $1.39K 10-Q · filed 2021-07-12 | $2.28K derived: sum of 4 quarters · filed 2022-03-21 | |||
| 2021-02-28 | $392.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $1.39K 10-Q · filed 2021-04-13 | $2.28K derived: sum of 3 quarters · filed 2022-03-21 | $2.97K derived: sum of 4 quarters · filed 2022-03-21 | |||
| 2020-12-31 | $1.00K 10-KT · filed 2022-03-21 | ||||||
| 2020-11-30 | $1.00K 10-Q · filed 2022-01-12 | $696.00 10-Q · filed 2021-01-14 | $1.88K derived: sum of 2 quarters · filed 2022-03-21 | $2.58K derived: sum of 3 quarters · filed 2022-03-21 | $4.67K derived: sum of 4 quarters · filed 2022-03-21 | ||
| 2020-08-31 | $884.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | $1.58K derived: sum of 2 quarters · filed 2022-03-21 | $3.67K derived: sum of 3 quarters · filed 2022-03-21 | $8.00K 10-KT · filed 2022-03-21 | $7.86K 10-K · filed 2020-11-04 | ||
| 2020-05-31 | $696.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | $2.78K derived: sum of 2 quarters · filed 2021-07-12 | $7.12K 10-Q · filed 2021-07-12 | $13.17K derived: sum of 4 quarters · filed 2021-07-12 | |||
| 2020-02-29 | $2.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $6.42K 10-Q · filed 2021-04-13 | $12.47K derived: sum of 3 quarters · filed 2021-04-13 | $16.62K derived: sum of 4 quarters · filed 2021-04-13 | |||
| 2019-11-30 | $4.33K 10-Q · filed 2021-01-14 | $10.39K derived: sum of 2 quarters · filed 2021-01-14 | $14.54K derived: sum of 3 quarters · filed 2021-01-14 | $18.92K derived: sum of 4 quarters · filed 2021-01-14 | |||
| 2019-08-31 | $6.05K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $10.20K derived: sum of 2 quarters · filed 2020-11-04 | $14.59K derived: sum of 3 quarters · filed 2020-11-04 | $18.28K 10-K · filed 2020-11-04 | |||
| 2019-05-31 | $4.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-13 | $8.54K derived: sum of 2 quarters · filed 2020-07-13 | $12.22K 10-Q · filed 2020-07-13 | $13.64K derived: sum of 4 quarters · filed 2020-07-13 | |||
| 2019-02-28 | $4.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $8.07K 10-Q · filed 2020-04-13 | $9.50K derived: sum of 3 quarters · filed 2020-04-13 | $11.39K derived: sum of 4 quarters · filed 2020-04-13 | |||
| 2018-11-30 | $3.69K 10-Q · filed 2020-01-14 | $5.11K derived: sum of 2 quarters · filed 2020-01-14 | $7.00K derived: sum of 3 quarters · filed 2020-01-14 | $13.63K derived: sum of 4 quarters · filed 2020-01-14 | |||
| 2018-08-31 | $1.42K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | $3.31K derived: sum of 2 quarters · filed 2019-12-18 | $9.94K derived: sum of 3 quarters · filed 2019-12-18 | $19.89K 10-K/A · filed 2019-12-18 | |||
| 2018-05-31 | $1.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-15 | $8.52K derived: sum of 2 quarters · filed 2019-07-15 | $18.47K 10-Q · filed 2019-07-15 | $39.78K derived: sum of 4 quarters · filed 2019-07-15 | |||
| 2018-02-28 | $6.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $16.58K 10-Q · filed 2019-04-15 | $37.89K derived: sum of 3 quarters · filed 2019-04-15 | $41.07K derived: sum of 4 quarters · filed 2019-04-15 | |||
| 2017-11-30 | $9.95K 10-Q · filed 2019-01-14 | $31.26K derived: sum of 2 quarters · filed 2019-01-14 | $34.44K derived: sum of 3 quarters · filed 2019-01-14 | $22.13K derived: sum of 4 quarters · filed 2019-01-14 | |||
| 2017-08-31 | $21.31K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $24.48K derived: sum of 2 quarters · filed 2018-11-29 | $12.18K derived: sum of 3 quarters · filed 2018-11-29 | $24.59K 10-K · filed 2018-11-29 | |||
| 2017-05-31 | $3.17K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-07-13 | -$9.13K derived: sum of 2 quarters · filed 2018-07-13 | $3.27K 10-Q · filed 2018-07-13 | $3.27K derived: sum of 4 quarters · filed 2018-07-13 | |||
| 2017-02-28 | -$12.31K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-05-14 | $100.00 10-Q/A · filed 2018-05-14 | $100.00 derived: sum of 3 quarters · filed 2018-05-14 | $3.95K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-11-30 | $12.41K 10-Q/A · filed 2018-03-21 | $12.41K derived: sum of 2 quarters · filed 2018-03-21 | $16.26K derived: sum of 3 quarters · filed 2018-03-21 | $16.26K derived: sum of 4 quarters · filed 2018-03-21 | |||
| 2016-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-29 | $3.85K derived: sum of 2 quarters · filed 2017-11-29 | $3.85K derived: sum of 3 quarters · filed 2017-11-29 | $4.45K 10-K · filed 2017-11-29 | |||
| 2016-05-31 | $3.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-21 | $3.85K derived: sum of 2 quarters · filed 2017-07-21 | $4.45K 10-Q · filed 2017-07-21 | ||||
| 2016-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-04-14 | $600.00 10-Q · filed 2017-04-14 | |||||
| 2015-11-30 | $600.00 10-Q · filed 2017-01-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |